Sialyl-Tn antigen expression in Crohn's colitis

Inflammatory Bowel Diseases

Volumn 3, Issue 4, 1997, Pages 254-259

  Ta, Alyssa ^a   Harpaz, Noam ^a   Bodian, Carol ^a   Roston, Alfred ^a   Oberman, Lee ^a   Chen, Anli ^a   Itzkowitz, Steven ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Colon cancer; Crohn's colitis; Immunohistochemistry; Mucin; Sialyl Tn; Ulcerative colitis

Indexed keywords

EID: 0004497786     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199712000-00002     Document Type: Article

References (30)

1. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989;52:257-331.
2. Hakomori S. Possible functions of tumor-associated carbohydrate antigens. Curr Opin Immunol 1991;3:646-53.
3. Itzkowitz SH, Yuan M, Montgomery CK, et al. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 1989;49:197-204.
4. Yonezawa S, Tachikawa T, Shin S, Sato E. Sialosyl-Tn antigen: its distribution in normal human tissues and expression in adenocarcinomas. Am J Clin Pathol 1992;98:167-74.
5. Ørntoft TF, Harving N, Langkilde NC. O-linked mucin-type glycoproteins in normal and malignant colon mucosa: lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas. Int J Cancer 1990;45:666-72.
6. Xu M, Real FX, Welt S, Schüssler MH, Oettgen HF, Old LJ. Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer. Int J Cancer 1989;44:985-9.
7. Itzkowitz SH, Bloom EJ, Lau TS, Kim YS. Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps. Gut 1992; 33:518-23.
8. Guadagni F, Roselli F, Cosimelli M, et al. Biologic evaluation of tumor-associated glycoprotein-72 and carcinoembryonic antigen expression in colorectal cancer, part I. DIs Colon Rectum 1994;37 (suppl):S16-23.
9. Itzkowitz SH, Marshall A, Kornbluth A, et al. Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis. Gastroenterology 1995;109:490-7.
10. Itzkowitz SH, Young E, Dubois D, et al. Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study. Gastroenterology 1996;110:694-704.
11. Thor A, Itzkowitz SH, Schlom J, Kim YS, Hanauer SB. Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis. Int J Cancer 1989;43:810-5.
12. Sachar DB. Cancer in Crohn's disease: dispelling the myths. Gut 1994;35:1507-8.
13. Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 1986;46:3118-24.
14. Kjeldsen T, Clausen H, Hirohashi S, Ogawa T, Iijima H, Hakomori S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6α-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res 1988;48: 2214-20.
15. Itzkowitz SH. Carbohydrate changes in colon carcinoma. Acta Pathol Microbiol Immunol Scand 1992;100(suppl 27):173-80.
16. Itzkowitz SH, Greenwald B, Meltzer SJ. Basic science review: colon carcinogenesis in inflammatory bowel disease. Inflammatory Bowel Dis 1995;1:142-58.
17. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;113:779-88.
18. Yuan M, Itzkowitz SH, Palekar A, et al. Distribution of blood group antigens A, B, H, Lewis a and Lewis b in human normal, fetal and malignant colonic tissue. Cancer Res 1985;45:4499-511.
19. Wiley EL, Mendelsohn G, Eggelston JC. Distribution of carcinoembryonic antigens and blood group substances in adenocarcinoma of the colon. Lab Invest 1981;44:507-13.
20. Cooper HS, Haesler WE. Blood group substances as tumor antigens in the distal colon. Am J Clin Pathol 1978;69:594-8.
21. Hughes NR, Walls RS, Newland RC, Payne JE. Gland to gland heterogeneity in histologically normal mucosa of colon cancer patients demonstrated by monoclonal antibodies to tissue-specific antigens. Cancer Res 1986;46:5993-9.
22. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin-2- and interferon-γ-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993;78:127-31.
23. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106:533-9.
24. Neurath MF, Meyer zum Büschenfelde KH. Protective and pathogenic roles of cytokines in inflammatory bowel diseases. J Invest Med 1996;44:516-21.
25. Mullin GE, Lazenby AJ, Harris ML, Bayless TM, James SP. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992;102:1620-7.
26. Mullin GE, Maycon ZR, Braun-Elwert L, et al. Inflammatory bowel disease mucosal biopsies have specialized lymphokine mRNA profiles. Inflammatory Bowel Dis 1996;2:16-26.
27. Guadagni F, Schlom J, Johnston WW, et al. Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells. JNCI 1989;81: 502-12.
28. 131I-CC49) when given in combination with γ-interferon. Cancer Res 1993;53:600-8.
29. Ogata S, Ho I, Chen A, et al. Tumor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa. Cancer Res 1995;55:1869-74.
30. Jass JR, Allison LM, Edgar S. Monoclonal antibody TKH2 to the cancer-associated epitope sialosyl-Tn shows cross-reactivity with variants of normal colorectal goblet cell mucin. Pathology 1994; 26:418-22.